30 Participants Needed

Spinal Cord Stimulation for Upper Extremity Function

Recruiting at 1 trial location
JD
Overseen ByJessica D'Amico, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method to help individuals regain arm and hand movement after a spinal cord injury or stroke. It employs a non-invasive treatment called transcutaneous spinal cord stimulation (tSCS), which delivers small electrical currents to the spinal cord. The goal is to determine the most effective ways to use this treatment to improve arm function. Individuals with a spinal cord injury at the neck level or a stroke affecting arm movement may be suitable candidates, particularly if their condition has been stable for some time. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants the opportunity to contribute to groundbreaking advancements in therapy.

Will I have to stop taking my current medications?

The trial requires that if you are taking medications for muscle relaxation or spasm control, your dose and schedule must be stable for at least 4 weeks before the trial starts. You don't need to stop these medications, but you can't change the dose or schedule right before joining.

What prior data suggests that transcutaneous spinal cord stimulation is safe for restoring upper extremity function?

Research has shown that transcutaneous spinal cord stimulation (tSCS) is generally safe for individuals with spinal cord injuries. Studies have found that, when combined with rehabilitation exercises, tSCS does not cause serious side effects. It has been tested in various settings, such as clinics and at home, and has improved upper body strength and function.

One study confirmed that tSCS is safe and effective, particularly for enhancing hand and arm functions. This indicates that the treatment is well-tolerated and beneficial without causing significant harm.

In summary, current research supports the safety of tSCS, especially when used with rehabilitation exercises, making it a promising option for improving upper body function after a spinal cord injury.12345

Why do researchers think this study treatment might be promising?

Transcutaneous Spinal Cord Stimulation (tSCS) is unique because it offers a non-invasive approach to improving upper extremity function, unlike traditional treatments that often rely on physical therapy alone. Researchers are excited about tSCS because it delivers electrical stimulation over the cervical spinal cord, potentially enhancing neural connections and motor function more effectively than standard rehab techniques. This method could provide a significant boost in recovery time and outcomes for individuals with impaired arm and hand mobility.

What evidence suggests that transcutaneous spinal cord stimulation is effective for improving upper extremity function after spinal cord injury or stroke?

Research has shown that transcutaneous spinal cord stimulation (tSCS) can enhance arm and hand movement in individuals with spinal cord injuries (SCI). One study demonstrated that tSCS, when combined with rehabilitation exercises, significantly improved arm and hand function in SCI patients. Another study found tSCS to be safe and effective, providing hope for restoring movement in the arms and hands. This trial will assess the effects of tSCS combined with rehabilitation exercises on upper extremity function. Although the exact effects on stroke patients remain under investigation, the results for SCI patients are promising.34567

Who Is on the Research Team?

JD

Jessica D'Amico, PhD

Principal Investigator

University of Alberta

Are You a Good Fit for This Trial?

This trial is for individuals who have experienced a stroke or spinal cord injury and are seeking to improve their upper extremity function. Specific eligibility criteria details were not provided, so interested participants should inquire further.

Inclusion Criteria

I had a stroke over 6 months ago and still have some arm movement.
I am between 18 and 75 years old with a spinal cord injury from C3 to C8, and it has been over a year since my injury.
My muscle relaxant dosage has been stable for at least 4 weeks.
See 2 more

Exclusion Criteria

I am taking medication that could lower my seizure threshold.
My muscle stiffness is severe.
I have difficulty speaking or understanding language.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive transcutaneous spinal cord stimulation over the cervical spinal cord with upper extremity training utilizing the ReJoyce system

8 weeks
Regular visits for stimulation and training sessions

Follow-up

Participants are monitored for changes in intracortical, corticospinal, and spinal excitability, as well as upper extremity function

6 months
Assessments at baseline, end of intervention, and 6-month follow-up

What Are the Treatments Tested in This Trial?

Interventions

  • Transcutaneous Spinal Cord Stimulation
Trial Overview The study tests noninvasive transcutaneous electrical stimulation (tcES) of the spinal cord to enhance arm function in those with spinal injuries or post-stroke. It explores how different settings affect nervous system activity and recovery.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: tSCS + RehabExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

Glenrose Foundation

Collaborator

Trials
10
Recruited
2,500+

Published Research Related to This Trial

Transcutaneous spinal cord stimulation (tSCS) can enhance muscle recruitment selectivity when using multielectrode configurations, as shown in a study with 16 participants, which may improve rehabilitation outcomes for paralyzed muscles after spinal cord injury.
The study found that spatially selective tSCS activates specific motor neurons through proprioceptive fibers, indicating a mechanism that could lead to more effective rehabilitation protocols targeting single-joint movements.
Enhanced selectivity of transcutaneous spinal cord stimulation by multielectrode configuration.Bryson, N., Lombardi, L., Hawthorn, R., et al.[2023]
Transcutaneous spinal cord stimulation (tSCS) shows potential for generating motor activity in individuals with spinal cord injury, but the overall quality of the studies reviewed was poor-to-fair, indicating a need for more rigorous research.
The review identified significant variability in stimulation parameters and outcome measurements across the 25 studies analyzed, highlighting the necessity for standardized methods to improve the reliability and comparability of tSCS research.
Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review.Taylor, C., McHugh, C., Mockler, D., et al.[2022]
Transcutaneous spinal cord stimulation (tSCS) can non-invasively enhance sensorimotor rehabilitation by modulating spinal cord circuitry, showing promise for improving recovery after spinal cord injuries.
Single-site tSCS can influence excitability across multiple spinal cord segments, while multi-site tSCS can enhance spinal reflexes and corticospinal networks, indicating its potential for more effective rehabilitation strategies.
Neural Substrates of Transcutaneous Spinal Cord Stimulation: Neuromodulation across Multiple Segments of the Spinal Cord.Barss, TS., Parhizi, B., Porter, J., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38958629/
Non-invasive Transcutaneous Spinal Cord Stimulation ...This study analyzes the stimulation parameters implemented during two successful trials that used non-invasive transcutaneous spinal cord stimulation (tSCS)
Non-invasive Transcutaneous Spinal Cord Stimulation ...This study analyzes the stimulation parameters implemented during two successful trials that used non-invasive transcutaneous spinal cord stimulation (tSCS)
Transcutaneous Spinal Cord Stimulation (ARC-EX Therapy ...Transcutaneous Spinal Cord Stimulation (ARC-EX Therapy) Is Safe and Effective at Improving Upper Extremity Function Following Spinal Cord Injury (P7-11.001).
NCT07147816 | Cervical Transcutaneous SCS for TBIThe goal of this study is to test the effects of non-invasive electrical stimulation of the spinal cord (called transcutaneous spinal cord stimulation, ...
Non-invasive spinal cord electrical stimulation for arm and ...These results demonstrate the safety and efficacy of ARC EX Therapy to improve hand and arm functions in people living with cervical SCI.
Cardiovascular safety of transcutaneous spinal cord ...This study supports the safety profile of cervical tSCS paired with rehabilitation in individuals with cervical spinal cord injury. The lack of ...
Safety and Effectiveness of Multisite Transcutaneous ...Objective. Evaluate the preliminary safety and efficacy of multi-site transcutaneous spinal cord stimulation (tSCS) combined with activity-based therapy (ABT) ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security